Navigation Links
CTI Issues Statement Regarding Tosedostat Clinical Trial
Date:6/24/2013

gn up for email alerts and get RSS feeds, please visit www.CellTherapeutics.com.

Forward-Looking Statements
This press release contains "forward-looking" statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning our anticipated product development and our ability to submit the above-referenced tosedostat data to the FDA in the coming weeks. Such statements are subject to risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results and the trading price of the Company's securities. Specifically, the risks and uncertainties that could affect our ability to address FDA requests or the development of tosedostat more generally include risks associated with preclinical and clinical developments in the biopharmaceutical industry in general and with tosedostat in particular including, without limitation, the potential failure of tosedostat to prove safe and effective as determined by the FDA and/or the European Medicines Agency; determinations by regulatory, patent, and administrative governmental authorities; competitive factors; technological developments; costs of developing and producing tosedostat; the risk that the FDA may expand its information request or initiate a complete clinical hold or take other actions; and the risk factors listed or described from time to time in the Company's filings with the Securities and Exchange Commission, including, without limitation, the Company's most recent filings on Forms 10-K, 10-Q and 8-K. The Company can give no assurances that any results or events projected or contemplated by its forward-looking statements will in fact occur and the Company cautions you not to place undue reliance on these statements. The Company undertakes no duty to update these forward-looking statements to reflect any future events, d
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests
2. Celsion Corporation Issues Statement Regarding Misleading Blog Entry
3. Zydus Pharmaceuticals USA Inc. Issues Voluntary Nationwide Recall of Warfarin 2 mg Tablets, Lot MM5767, Expiration Date June 2014, Due to Oversized Tablets
4. Endeavor Power Corporation Issues Corrections on two of its earlier Press Releases dated January 9, 2013 and March 8, 2013
5. Neiman Center Issues Policy Brief Outlining Innovative Health Care Payment Models to Provide Cost-Effective Specialty Care for Patients
6. ISPE Patient Initiative Issues Survey Regarding Patient Experience with Clinical Materials
7. Ampio Pharmaceuticals Issues Statement Regarding Misleading Blog
8. American Academy of Ophthalmology Issues Statement on Provisions to Pharmaceutical Compounding Quality and Accountability Act
9. Royalty Pharma Issues Investor Presentation Highlighting The Strategic And Financial Advantages Of Its Offer To Acquire Elan For $12.50 Per Share In Cash
10. BD Issues 2012 Sustainability Report
11. TNI BioTech, Inc. Corporations CEO Issues Letter to Shareholders Discussing Recent Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... Oct. 31, 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ...  What: , Isis Pharmaceuticals, Third Quarter 2014 Financial ... 7 at 11:30 a.m. ET / 8:30 a.m. PTWhere: ... the Internet. Simply log onto our website listed above. ... event, a replay of the webcast will be available ...
(Date:10/30/2014)... /CNW/ - Atlantic Canadians will save an estimated $560-million ... Canada,s provinces and territories and the generic ... Canadian Generic Pharmaceutical Association (CGPA), said today. ... the Atlantic Summit on Healthcare and Drug Cost Sustainability ... hosted by the Public Policy Forum and sponsored by ...
(Date:10/30/2014)... , Oct. 30, 2014   NxStage® Kidney Care, ... NXTM ), is proud to host the grand opening ... center at 1600 W. 16 th Street on November ... operated by highly trained medical staff who are committed to ... quality of life benefits made possible through more flexible dialysis ...
Breaking Medicine Technology:Webcast Alert: Isis Pharmaceuticals' Third Quarter 2014 Financial Results Conference Call 2Webcast Alert: Isis Pharmaceuticals' Third Quarter 2014 Financial Results Conference Call 3Atlantic Canadians to Save $560-Million Through Unprecedented Three-Year Pan-Canadian Agreement on Generic Prescription Medicines 2Atlantic Canadians to Save $560-Million Through Unprecedented Three-Year Pan-Canadian Agreement on Generic Prescription Medicines 3Grand Opening of NxStage Kidney Care Oak Brook IL Center 2Grand Opening of NxStage Kidney Care Oak Brook IL Center 3
... Dec. 12, 2010 Nektar Therapeutics (Nasdaq: ... a Phase 2 clinical study evaluating single-agent NKTR-102 ... 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium ... conjugate, is Nektar,s lead oncology candidate and is ...
... THE WOODLANDS, Texas, Dec. 10, 2010 Joyce ... Breast Cancer Research Committee, US Oncology Research , ... Cancer Center, presented her study findings today at the ... ), an international scientific symposium for interaction and exchange ...
Cached Medicine Technology:NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients 2NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients 3NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients 4NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients 5NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients 6NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients 7NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients 8NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients 9Cancer Patients May Reduce Fast Growing Breast Cancer Recurrences: Findings Reported at 2010 San Antonio Breast Cancer Symposium 2Cancer Patients May Reduce Fast Growing Breast Cancer Recurrences: Findings Reported at 2010 San Antonio Breast Cancer Symposium 3Cancer Patients May Reduce Fast Growing Breast Cancer Recurrences: Findings Reported at 2010 San Antonio Breast Cancer Symposium 4Cancer Patients May Reduce Fast Growing Breast Cancer Recurrences: Findings Reported at 2010 San Antonio Breast Cancer Symposium 5
(Date:10/31/2014)... Denver, Colorado (PRWEB) October 31, 2014 The ... program was created by Alexander Lynch, whose father suffered from ... through a dramatic moment, caused by his father's disease. His ... crisis. That was the crucial moment when the author of ... help his dad. , The Memory Healer program is ...
(Date:10/31/2014)... (PRWEB) October 31, 2014 With all ... one Midwest optometrist feels they may overlook one critical ... affect areas like concentration, school performance and even behavior. ... too brief to identify progressive vision problems, and to ... Mo., announces a new initiative: The Awesome Eyes Student ...
(Date:10/31/2014)... (HealthDay News) -- Obesity increases the risk of certain ... women, two new U.S. studies show. One study ... or obese increased the risk for estrogen receptor-negative and ... known this for a long time for white women, ... women," study author Esther John, a senior research scientist ...
(Date:10/31/2014)... Santa Barbara, CA (PRWEB) October 31, 2014 ... for holiday shoppers to find affordable but tasteful gifts for ... special 22nd Annual Early Bird Gift Giving Special , ... percent off when they purchase Wine Club Gift membership. ... to take advantage of this special. Besides offering discounts, Gold ...
(Date:10/31/2014)... 31, 2014 Florida Air Academy, ... girls in grades 6-12, is taking the lead ... injuries and concussions, becoming the first high school ... (Immediate Post-Concussion Assessment and Cognitive Testing) computerized assessment ... Player' lawsuit grabs the headlines, and the Centers ...
Breaking Medicine News(10 mins):Health News:"Memory Healer" Review Reveals a New Natural Remedy Guide for Managing Memory Loss 2Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 2Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 3Health News:Study Confirms Obesity-Breast Cancer Link for Blacks, Hispanics 2Health News:Gold Medal Wine Club now offering Early Bird Gift Giving Special for Holidays 2Health News:Florida Air Academy Tackling Concussions Head-On 2Health News:Florida Air Academy Tackling Concussions Head-On 3
... Kerr, MD,Director of the Bowen Center for the Study ... address the topic of autism in the,family., ASD ... widely,discussed and intensively researched clinical entities in medicine.,Passionate debate ... the,number of children diagnosed to be on the autistic ...
... Southern Home Medical,Equipment, Inc. (OTC: SHOM) announced today that ... in the second quarter of 2008,compared to the first ... Company, stated, "We have focused a significant portion of ... Encore Medical Staffing. We are,very excited to see that ...
... (Nasdaq: RURL ) issued another reminder today for ... Company,s common stock in relation,to its ongoing analysis of ... U.S. Internal Revenue Code ("Section 382")., In general, ... operating,losses and certain other tax benefits following a change ...
... Should Know Their Income History; Allsup Answers Common Benefits Questions ... ... who find themselves with a mental or physical disability face many ... accept that they no longer can work. While everything about a ...
... Gastroenterology care, selects MxSecure, Inc., the nation's leading provider of ... transcription provider for accurate and timely transcription reports. , ... ... - MxSecure, Inc , the nation's leading provider of ...
... Study is one of few trials to recruit large percentage of African ... ... Keeping a food diary can double,a person,s weight loss according to ... of the largest and longest,running weight loss maintenance trials ever conducted, will ...
Cached Medicine News:Health News:Southern Home Medical Reports Its Encore Medical Staffing Division Increases Revenues by 63% 2Health News:Rural/Metro Issues Reminder to Stockholders on Transactions That May Impact IRS Section 382 Outcome 2Health News:Rural/Metro Issues Reminder to Stockholders on Transactions That May Impact IRS Section 382 Outcome 3Health News:Past Earnings Play Role in Determining SSDI Benefits 2Health News:Past Earnings Play Role in Determining SSDI Benefits 3Health News:Past Earnings Play Role in Determining SSDI Benefits 4Health News:Past Earnings Play Role in Determining SSDI Benefits 5Health News:Central Bucks Specialists, a Cardiology and Gastroenterology Multi-location Clinic, Selects MxSecure, Inc., Provider of Medical Transcription Services, as their Transcription Provider. 2Health News:Central Bucks Specialists, a Cardiology and Gastroenterology Multi-location Clinic, Selects MxSecure, Inc., Provider of Medical Transcription Services, as their Transcription Provider. 3Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 2Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 3Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: